Linus Pauling Institute

Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.

Jump DB, Depner CM, Tripathy S, Lytle KA.  2016.  Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.. Proc Nutr Soc. 75(1):1-9.

Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.

Jump DB, Depner CM, Tripathy S.  2012.  Omega-3 fatty acid supplementation and cardiovascular disease.. J Lipid Res. 53(12):2525-45.

Jump DB, Torres-Gonzalez M, L Olson K.  2011.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.. Biochem Pharmacol. 81(5):649-60.

Jump DB.  2011.  Fatty acid regulation of hepatic lipid metabolism.. Curr Opin Clin Nutr Metab Care. 14(2):115-20.

Jump DB.  2009.  Mammalian fatty acid elongases.. Methods Mol Biol. 579:375-89.

Jump DB.  2008.  N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.. Curr Opin Lipidol. 19(3):242-7.